63 Pharmaceutical R&D companies

Cambrian Biopharma is building the medicines that will redefine healthcare in the 21st century – therapeutics to lengthen healthspan, the period of life spent i…

AstraZeneca is a global biopharmaceutical company that researches, develops, and commercializes prescription medicines in oncology, respiratory, and rare diseas…

Novartis is a Basel-headquartered global pharmaceutical company developing innovative medicines, employing approximately 109,000 people and reaching over 280 mi…

Debiopharm invests in Smart Data & Digital Health companies developing technologies that are applicable in the areas of oncology or infectious diseases.

Igniting the path to sustainable and affordable innovation.

Takeda Ventures focuses on high-caliber therapeutic and platform based opportunities around the world.

Equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

We are a venture capital firm investing in about-to-be clinical and clinical stage private companies in Europe and the USA.

Pfizer Ventures invests in areas of current or future strategic interest to Pfizer with the goal of remaining at the forefront of life science advances. We iden…

Droia Ventures is a specialist investor, dedicated to making an impact and save patient lives.

We are i&i Biotech Fund (i&i Bio), partners of outstanding founders on their path to global success.

Aditum Bio is a new model of biotech venture capital, uniquely positioned to rapidly translate scientific discoveries into innovative new medicines.

Bayer is a global life science company with core competencies in healthcare and agriculture, committed to "Health for all, Hunger for none" through scientific i…

We are long-term investors in engineering biology to treat - or better, cure - human disease.

We are a venture studio leveraging Alloy’s pre-competitive drug discovery platforms. Established drug discovery, scientific, and lab resources allow entrepreneu…

A venture capital firm uniquely dedicated to the frontier of neuroscience.

Identifying true innovations and building ambitious companies.

Accelerating early-stage innovation through strategic partnership.

Investing in the future of healthcare.

RA Capital funds and builds healthcare and life science companies.